Gibbs PH - Search Results

1

Evaluation of a new Rift Valley fever vaccine: safety and immunogenicity trials.

Meadors GF 3rd, Gibbs PH, Peters CJ. Meadors GF 3rd, et al. Among authors: gibbs ph. Vaccine. 1986 Sep;4(3):179-84. doi: 10.1016/0264-410x(86)90007-1. Vaccine. 1986. PMID: 3532605 Clinical Trial.

2

Immunogenicity of an inactivated Rift Valley fever vaccine in humans: a 12-year experience.

Pittman PR, Liu CT, Cannon TL, Makuch RS, Mangiafico JA, Gibbs PH, Peters CJ. Pittman PR, et al. Among authors: gibbs ph. Vaccine. 1999 Aug 20;18(1-2):181-9. doi: 10.1016/s0264-410x(99)00218-2. Vaccine. 1999. PMID: 10501248

3

Pathogenesis of Rift Valley fever in rhesus monkeys: role of interferon response.

Morrill JC, Jennings GB, Johnson AJ, Cosgriff TM, Gibbs PH, Peters CJ. Morrill JC, et al. Among authors: gibbs ph. Arch Virol. 1990;110(3-4):195-212. doi: 10.1007/BF01311288. Arch Virol. 1990. PMID: 1690534

4

Prevention of Rift Valley fever in rhesus monkeys with interferon-alpha.

Morrill JC, Jennings GB, Cosgriff TM, Gibbs PH, Peters CJ. Morrill JC, et al. Among authors: gibbs ph. Rev Infect Dis. 1989 May-Jun;11 Suppl 4:S815-25. doi: 10.1093/clinids/11.supplement_4.s815. Rev Infect Dis. 1989. PMID: 2546250

5

Hemostatic derangement produced by Rift Valley fever virus in rhesus monkeys.

Cosgriff TM, Morrill JC, Jennings GB, Hodgson LA, Slayter MV, Gibbs PH, Peters CJ. Cosgriff TM, et al. Among authors: gibbs ph. Rev Infect Dis. 1989 May-Jun;11 Suppl 4:S807-14. doi: 10.1093/clinids/11.supplement_4.s807. Rev Infect Dis. 1989. PMID: 2749112

6

Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine.

Pittman PR, Makuch RS, Mangiafico JA, Cannon TL, Gibbs PH, Peters CJ. Pittman PR, et al. Among authors: gibbs ph. Vaccine. 1996 Mar;14(4):337-43. doi: 10.1016/0264-410x(95)00168-z. Vaccine. 1996. PMID: 8744562 Clinical Trial.

7

Protective efficacy of a live attenuated vaccine against Argentine hemorrhagic fever. AHF Study Group.

Maiztegui JI, McKee KT Jr, Barrera Oro JG, Harrison LH, Gibbs PH, Feuillade MR, Enria DA, Briggiler AM, Levis SC, Ambrosio AM, Halsey NA, Peters CJ. Maiztegui JI, et al. Among authors: gibbs ph. J Infect Dis. 1998 Feb;177(2):277-83. doi: 10.1086/514211. J Infect Dis. 1998. PMID: 9466512 Clinical Trial.

8

Immunogenicity and safety of an inactivated Rift Valley fever vaccine in a 19-year study.

Rusnak JM, Gibbs P, Boudreau E, Clizbe DP, Pittman P. Rusnak JM, et al. Vaccine. 2011 Apr 12;29(17):3222-9. doi: 10.1016/j.vaccine.2011.02.037. Epub 2011 Feb 26. Vaccine. 2011. PMID: 21354483

9

Immune interference after sequential alphavirus vaccine vaccinations.

Pittman PR, Liu CT, Cannon TL, Mangiafico JA, Gibbs PH. Pittman PR, et al. Among authors: gibbs ph. Vaccine. 2009 Aug 6;27(36):4879-82. doi: 10.1016/j.vaccine.2009.02.090. Epub 2009 Mar 11. Vaccine. 2009. PMID: 19576665

10

Immune interference in the setting of same-day administration of two similar inactivated alphavirus vaccines: eastern equine and western equine encephalitis.

Reisler RB, Gibbs PH, Danner DK, Boudreau EF. Reisler RB, et al. Among authors: gibbs ph. Vaccine. 2012 Nov 26;30(50):7271-7. doi: 10.1016/j.vaccine.2012.09.049. Epub 2012 Sep 29. Vaccine. 2012. PMID: 23031498

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45 results

Search Page

Filters